Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study.
Frenck RW Jr, Naficy A, Feser J, Dickey MP, Leyva-Grado VH, Egan MA, Chen T, Eldridge JH, Sciotto-Brown S, Hermida L, Promeneur D, Luckay A, Medina H, Lazaro GA, Patel NR, Naqvi T, Broder CC, Dimitrov AS, Gast C, Mercer LD, Raine M, Andi-Lolo I, Innis BL, Aponte JJ, Hamm S, Rathi N.
Frenck RW Jr, et al. Among authors: chen t.
Lancet. 2025 Dec 13;406(10521):2792-2803. doi: 10.1016/S0140-6736(25)01390-X. Epub 2025 Nov 14.
Lancet. 2025.
PMID: 41248666
Clinical Trial.